Browsing: Pfizer’s Paxlovid not included in China’s national insurance

Chinese health care authorities declined to include Pfizer’s covid19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive.